Lung cancer remains the leading cause of cancer death worldwide [1], and non-small-cell lung cancer (NSCLC) accounts for approximately 85% of cases, with up to 50% of Asian patients harboring epidermal growth factor receptor (EGFR) mutations [2]. This evidence concerns the gene EGFR and cancer.